JRAMAIL TYLER: Open Payments
NPI 1407482011 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,048 in 24 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,048
Food & beverage: $580Education: $468
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $494 |
| SOBI, INC | 3 | $164 |
| Syndax Pharmaceuticals, Inc. | 4 | $133 |
| Lilly USA, LLC | 3 | $75 |
| AstraZeneca Pharmaceuticals LP | 2 | $65 |
| Incyte Corporation | 2 | $58 |
| ABBVIE INC. | 1 | $33 |
| Merck Sharp & Dohme LLC | 1 | $26 |
Products named: Cresemba, JAYPIRCA, CALQUENCE, Vonjo, JAKAFI, EPKINLY, Xospata.
Industry payments across TX — which companies pay providers there.
